Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 13 | 11 | 2 | 10,479 | 12 |
| Gross Profit | 13 | 11 | 2 | 10,479 | 12 |
| Operating Expenses | 20,076 | 17,351 | 14,376 | 14,286 | 12,749 |
| Operating Income | -20,063 | -17,340 | -14,374 | -3,807 | -12,737 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Other Income | -771 | -29 | 1,329 | -656 | 4,195 |
| Pre-tax Income | -20,834 | -17,369 | -13,045 | -4,463 | -8,543 |
| Income Tax | 15 | 18 | 280 | N/A | -2,477 |
| Net Income Continuous | -20,849 | -17,387 | -13,325 | -4,463 | -6,066 |
| Net Income | $-20,849 | $-17,387 | $-13,325 | $-4,463 | $-6,066 |
| EPS Basic Total Ops | -0.90 | -0.74 | -0.57 | -0.19 | -0.23 |
| EPS Basic Continuous Ops | -0.89 | -0.74 | -0.57 | -0.19 | -0.25 |
| EPS Diluted Total Ops | -0.90 | -0.74 | -0.57 | -0.19 | -0.20 |
| EPS Diluted Continuous Ops | -0.89 | -0.74 | -0.57 | -0.19 | -0.22 |
| EBITDA(a) | $-20,040 | $-17,281 | $-14,385 | $-3,803 | $-12,576 |